A-12 Core Urinary Control
Bladder Function & Urinary Support
Compounds explored for their interaction with growth hormone secretagogue receptors, GH-releasing pathways, and endocrine signaling cascades.
Showing 1–16 of 22 results






A combined lyophilized research reagent containing a tetrasubstituted Growth Hormone-Releasing Hormone (GHRH) analog and a selective Growth Hormone Secretagogue (GHS). This blend is designed for research applications aiming to investigate the synergistic stimulation of the somatotropic axis through simultaneous activation of GHRH and ghrelin receptors.
Trust & Quality Verification

A high-purity, lyophilized synthetic tetrasubstituted peptide analogue of Growth Hormone-Releasing Hormone (GHRH), formally classified in scientific literature as Modified GRF (1-29). Characterized strictly for research applications involving the somatotropic axis, physiological pulsatile growth hormone (GH) secretion, and neuroendocrine receptor signaling.
Trust & Quality Verification

A high-purity, lyophilized synthetic long-acting peptide analogue of Growth Hormone-Releasing Hormone (GHRH), modified with a C-terminal Drug Affinity Complex (DAC). It is widely investigated in research models for its ability to covalently bind to serum albumin, resulting in sustained somatotropic axis stimulation, continuous GH/IGF-1 elevation, and prolonged metabolic flux.
Trust & Quality Verification

A high-purity, recombinant glycoprotein and potent antagonist of the TGF-$\beta$ superfamily ligands, specifically Myostatin (GDF-8) and Activin A. Follistatin is extensively utilized in research models to investigate skeletal muscle hypertrophy, the regulation of adipocyte differentiation, and the modulation of inflammatory fibrosis.
Trust & Quality Verification

A high-purity, lyophilized synthetic polypeptide matching the endogenous 44-amino acid sequence of Growth Hormone-Releasing Hormone (GHRH). Characterized for research applications involving the hypothalamic-pituitary-somatotropic axis, pulsatile hormone secretion dynamics, and neuroendocrine receptor signaling.
Trust & Quality Verification

A high-purity, multi-peptide lyophilized blend engineered for comprehensive somatotropic axis research. This specialized combination incorporates growth hormone-releasing hormone (GHRH) analogues, selective ghrelin receptor agonists, and an insulin-like growth factor-1 (IGF-1) splice variant to investigate synergistic neuroendocrine signaling, metabolic flux, and tissue regeneration pathways.
Trust & Quality Verification

A high-purity, lyophilized dimeric glycoprotein structurally identical to endogenous Human Chorionic Gonadotropin (HCG). It is extensively utilized in research models to investigate gonadal steroidogenesis, luteal cell regulation, and the modulation of early embryonic development pathways.

A high-purity, lyophilized synthetic hexapeptide growth hormone secretagogue (GHS). Characterized strictly for research applications involving somatotropic axis stimulation, CD36-mediated cardioprotection, and ischemic injury recovery models.
Trust & Quality Verification

A high-purity, lyophilized multi-peptide blend combining a potent synthetic hexapeptide growth hormone secretagogue (Hexarelin) and a tetrasubstituted Growth Hormone-Releasing Hormone analogue (CJC 1295 no DAC, also known as Modified GRF 1-29). Characterized strictly for research applications involving the synergistic amplification of the somatotropic axis, CD36-mediated cardioprotection, and acute, physiological pulsatile neuroendocrine signaling.
Trust & Quality Verification

A high-purity, lyophilized synthetic peptide fragment derived from the C-terminal sequence (amino acids 176-191) of human growth hormone (hGH). Characterized strictly for research applications involving the isolated modulation of lipid metabolism, lipolysis stimulation, and beta-3 adrenergic receptor expression pathways independent of somatotropic activity.
Trust & Quality Verification

A high-purity, lyophilized glycoprotein mixture of Human Menopausal Gonadotropin (HMG), also known as Menotropin. It contains a physiological 1:1 ratio of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) activity. It is widely characterized for research applications involving gonadal steroidogenesis, cellular hyperstimulation models, and the investigation of the cAMP/PKA intracellular signaling axis.
Trust & Quality Verification